Vanadium compounds in medicine

JC Pessoa, S Etcheverry, D Gambino - Coordination chemistry reviews, 2015 - Elsevier
Vanadium is a transition metal that, being ubiquitously distributed in soil, crude oil, water
and air, also found roles in biological systems and is an essential element in most living …

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches

JA Urbina - Acta tropica, 2010 - Elsevier
A critical review of the development of specific chemotherapeutic approaches for the
management of American Trypanosomiasis or Chagas disease is presented, including …

[HTML][HTML] WHF IASC roadmap on Chagas disease

LE Echeverría, R Marcus, G Novick, S Sosa-Estani… - Global …, 2020 - ncbi.nlm.nih.gov
Background: Chagas Disease is a neglected tropical disease caused by the protozoan
Trypanosoma cruzi, with some of the most serious manifestations affecting the …

Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives

JA Urbina - Journal of Eukaryotic Microbiology, 2015 - Wiley Online Library
Chagas disease, a chronic systemic parasitosis caused by the Kinetoplastid protozoon
Trypanosoma cruzi, is the first cause of cardiac morbidity and mortality in poor rural and …

Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives

M Navarro, C Gabbiani, L Messori, D Gambino - Drug discovery today, 2010 - Elsevier
Tropical diseases today constitute a major health problem and a big challenge for drug
discovery. Because of the limited arsenal of effective antiparasitic agents and the frequent …

Tolerance and safety of nifurtimox in patients with chronic chagas disease

Y Jackson, E Alirol, L Getaz, H Wolff… - Clinical Infectious …, 2010 - academic.oup.com
Background. Nifurtimox has been used to treat Chagas disease for 40 years, but tolerance
and safety data in adults are scarce. We aimed to evaluate nifurtimox tolerance and safety in …

Chagas disease diagnostic applications: present knowledge and future steps

V Balouz, F Agüero, CA Buscaglia - Advances in parasitology, 2017 - Elsevier
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a lifelong and debilitating
illness of major significance throughout Latin America and an emergent threat to global …

Potentiality of vanadium compounds as anti-parasitic agents

D Gambino - Coordination Chemistry Reviews, 2011 - Elsevier
Research efforts on the medicinal chemistry of vanadium have been mainly focused whether
on improving biodistribution and tolerability of the vanadium insulin-enhancing core or on …

[HTML][HTML] The BENEFIT trial: where do we go from here?

B Pecoul, C Batista, E Stobbaerts… - PLoS neglected …, 2016 - journals.plos.org
In the next five years, we can now project that 200,000 people living with Chagas disease
will die from heart disease and related complications. We urgently need to redouble our …

Chagas cardiomyopathy—where do we stand after a hundred years?

A Biolo, AL Ribeiro, N Clausell - Progress in cardiovascular diseases, 2010 - Elsevier
A hundred years from its description, Chagas cardiomyopathy remains a challenging
disease. Although successful vector-control strategies have decreased the incidence of …